Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn
Research Article

P. INTERRELATIONSHIPS OF CATECHOLAMINES WITH OTHER ENDOCRINE SYSTEMS

B. B. Brodie, J. I. Davies, S. Hynie, G. Krishna and B. Weiss
Pharmacological Reviews March 1966, 18 (1) 273-289;
B. B. Brodie
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. I. Davies
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Hynie
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Krishna
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. Weiss
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Rats whose adrenergic nerve function has been blocked are similar to adrenalectomized rats in their responses to external stimuli that require an increased expenditure of energy. The basal metabolism is almost normal; but on exposure to cold or to muscular work, neither animal can elicit piloerection, vasoconstriction or shivering; nor do they show lipolytic or glycogenolytic responses to epinephrine. The finding that epinephrine fails to restore these responses in adrenalectomized animals indicates that the incapacity of these animals to withstand cold or strenuous work results from failure of sympathetic target organs to respond to transmitted messages. Communications are re-established by aldosterone as well as glucocorticoids, suggesting that the inexcitability of adrenergic receptors after adrenalectomy is related to changes in electrolytes.

An important contribution to biology has been the concept of Sutherland and co-workers that cyclic 3',5'-AMP is the chemical trigger mediating catecholamine action in sympathetic target organs. These authors have outlined the various steps in the activation of phosphorylase by catecholamines. Some of the steps in the activation of another sympathetic function, the breakdown of triglycerides to FFA, may be outlined as follows:

Catecholamines stimulate lipolysis by causing an instantaneous activation of adenyl cyclase, thereby increasing the steady-state level of cyclic 3',5'-AMP. This response, however, is limited by the destruction of cyclic 3',5'-AMP by phosphodiesterase. On the other hand, the steady-state level of cyclic 3',5'-AMP is increased still further by theophylline, which inhibits phosphodiesterase. As a result, lipase is activated to a much greater extent by theophylline than by the catecholamines.

The effect of catecholamines is inhibited by such diverse compounds as beta-adrenergic blocking agents and nicotinic acid. The beta blocking agents act by competitively blocking catecholamines at adenyl cyclase, whereas the inhibitory effects of nicotinic acid appear to be due, at least in part, to stimulation of phosphodiesterase. This action would explain why nicotinic acid has such a marked effect on the basal output of FFA. In addition, the effects of catecholamines are prevented by adrenalectomy, presumably through lack of proper ionic environment at the receptor site.

Finally, treatment with thyroid hormone induces the formation of additional adenyl cyclase; in contrast, thyroidectomy reduces the amount of enzyme. In neither case is the amount of lipase affected. Should these effects on the fat pad be typical of other thyroid functions, the interplay between these systems could be explained by a given amount of catecholamine activating a larger amount of adenyl cyclase. As a logical extension of this view, certain actions of thyroid hormones should be diminished after sympathectomy. This might explain why certain sympatholytic agents produce ameliorative effects in patients with hyperthyroidism.

PharmRev articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Pharmacological Reviews
Vol. 18, Issue 1
1 Mar 1966
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Pharmacological Reviews article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
P. INTERRELATIONSHIPS OF CATECHOLAMINES WITH OTHER ENDOCRINE SYSTEMS
(Your Name) has forwarded a page to you from Pharmacological Reviews
(Your Name) thought you would be interested in this article in Pharmacological Reviews.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research Article

P. INTERRELATIONSHIPS OF CATECHOLAMINES WITH OTHER ENDOCRINE SYSTEMS

B. B. Brodie, J. I. Davies, S. Hynie, G. Krishna and B. Weiss
Pharmacological Reviews March 1, 1966, 18 (1) 273-289;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research Article

P. INTERRELATIONSHIPS OF CATECHOLAMINES WITH OTHER ENDOCRINE SYSTEMS

B. B. Brodie, J. I. Davies, S. Hynie, G. Krishna and B. Weiss
Pharmacological Reviews March 1, 1966, 18 (1) 273-289;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics